AGO vs DNP

The Advanced Deterministic Scorecard reveals a weak Piotroski F-Score of 3/9, indicating poor financial health, while the absence of an Altman Z-Score prevents a definitive distress risk assessment. Despite this, AGO trades below the Graham Number of $148.07 at $83.26, suggesting potential undervaluation, supported by a low P/E of 10.36 versus sector average of 22.56. However, declining earnings growth (YoY: -31.20%) and negative insider sentiment counterbalance value appeal. Analysts recommend a 'buy' with a $107.00 target, implying upside, but inconsistent quarterly execution and bearish technical trend temper near-term optimism.

DNP exhibits a stable financial profile with a Piotroski F-Score of 5/9 and a strong defensive valuation, trading significantly below its Graham Number of $15.59. While the fund offers an attractive dividend yield of 7.28% and low leverage (Debt/Equity 0.32), it is currently facing a severe earnings contraction of -73.40% YoY. The discrepancy between the bearish technical trend score (10/100) and the positive 1-year price performance (+21.3%) suggests a potential divergence between short-term momentum and long-term fundamentals. Overall, it remains a viable income vehicle, but the sharp decline in earnings growth limits a bullish rating.